Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America

Brazilian Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 2, 2010, Pages

  Alvarez, Carlos ^a   Labarca, Jaime ^b   Salles, Mauro ^c  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

Author keywords

Infection control; Latin america; Mrsa; Prevention

Indexed keywords

CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PANDEMIC; REVIEW; RISK FACTOR; SOUTH AND CENTRAL AMERICA;

EID: 78650808591     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702010000800006     Document Type: Review

References (90)

1. Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961; 14:385-93.
2. Chabbert YA, Baudens JG. Souches de staphylocoques resistants naturellement a la meticilline et a la 5 methyl-3-phenyl-4-iso-oxazyl penicilline (P12). Annales de l'Institut Pasteur. 1962; 103:222-30.
3. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006; 355(7):666-74.
4. Struelens MJ. Guidelines and indicators for methicillin-resistant Staphylococcus aureus control in hospitals: toward international agreement? Curr Opin Infect Dis. 2009; 22(4):337-8.
5. Struelens N. Methicillin-resistant Staphylococcus aureus public concern, and legislative mandates. Infect Control Hosp Epidemiol. 2007; 28(7):896.
6. Guzmán-Blanco M, Mejía C, Isturiz R et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents. 2009; 34(4):304-8.
7. Rodríguez-Noriega E, Seas C, Guzmán-Blanco M et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010; 14:e560-6.
8. Calfee DP, Salgado CD, Classen D et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29(Suppl 1):S62-80.
9. Gould FK, Brindle R, Chadwick PR et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother. 2009; 63(5):849-61.
10. Siegel J, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in healthcare settings. Healthcare Infection Control Practices Advisory Committee, 2006.
11. Muto CA, Jernigan JA, Ostrowsky BE et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003; 24(5):362-86.
12. Coia JE, Duckworth GJ, Edwards DI et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006; 63(Suppl 1):S1-44.
13. Belgian Superior Health Council. Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals. 2005.
14. Rodríguez-Baño J, Bischofberger C, Alvarez-Lerma F et al. Surveillance and control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A GEIH-SEIMC and SEMPSPH consensus document. Enferm Infecc Microbiol Clin. 2008; 26(5):285-98.
15. Richet HM, Benbachir M, Brown DE et al. Are there regional variations in the diagnosis, surveillance, and control of methicillin- resistant Staphylococcus aureus? Infect Control Hosp Epidemiol. 2003; 24(5):334-41.
16. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002; 136(11):834-44.
17. Semmelweis I. The etiology, concept, and prophylaxis of childbed fever. Madison and London: University of Wisconsin Press, 1983.
18. Opal SM, Mayer KH, Stenberg MJ et al. Frequent acquisition of multiple strains of methicillin-resistant Staphylococcus aureus by healthcare workers in an endemic hospital environment. Infect Control Hosp Epidemiol. 1990; 11(9):479-85.
19. Zachary KC, Bayne PS, Morrison VJ et al. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2001; 22(9):560-4.
20. Devine J, Cooke RP, Wright EP. Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nosocomial MRSA transmission and handwashing compliance? J Hosp Infect. 2001; 48(1):72-5.
21. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol. 1997; 18(9):622-7.
22. Boyce JM, Chenevert C. Isolation gowns prevent health care workers (HCWs) from contaminating their clothing, and possibly their hands, with methicillin-resistant Staphylococcus aureus (MRSA) and resistant enterococci. Presented at the Eighth Annual Meeting of the Society for Healthcare Epidemiology of America. Orlando, USA, 1998.
23. Brooks S, Khan A, Stoica D et al. Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol. 1998; 19(5):333-6.
24. Singh D, Kaur H, Gardner WG, Treen LB. Bacterial contamination of hospital pagers. Infect Control Hosp Epidemiol. 2002; 23(5):274-6.
25. Ulger F, Esen S, Dilek A et al. Are we aware how contaminated our mobile phones with nosocomial pathogens? Ann Clin Microbiol Antimicrob. 2009; 8:7.
26. Oie S, Kamiya A. Survival of methicillin-resistant Staphylococcus aureus (MRSA) on naturally contaminated dry mops. J Hosp Infect. 1996; 34(2):145-9.
27. Neely AN, Maley MP. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol. 2000; 38(2):724-6.
28. Dietze B, Rath A, Wendt C, Martiny H. Survival of MRSA on sterile goods packaging. J Hosp Infect. 2001; 49(4):255-61.
29. Tacconelli E, De Angelis G, Cataldo MA et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and metaanalysis. J Antimicrob Chemother. 2008; 61(1):26-38.
30. Jernigan JA, Titus MG, Groschel DH et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol. 1996; 143(5):496-504.
31. Marshall C, Harrington G, Wolfe R et al. Acquisition of methicillin- resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol. 2003; 24(5):322-6.
32. Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol. 2006; 27(2):116-21.
33. Nicolle LE, Dyck B, Thompson G et al. Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Manitoba Chapter of CHICA-Canada. Infect Control Hosp Epidemiol. 1999; 20(3):202-5.
34. Kotilainen P, Routamaa M, Peltonen R et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med. 2001; 161(6):859-63.
35. Cooper CL, Dyck B, Ormiston D et al. Bed utilization of patients with methicillin-resistant Staphylococcus aureus in a Canadian tertiary-care center. Infect Control Hosp Epidemiol. 2002; 23(9):483-4.
36. Wernitz MH, Swidsinski S, Weist K et al. Effectiveness of a hospital-wide selective screening programme for methicillinresistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect. 2005; 11(6):457-65.
37. Tomic V, Svetina Sorli P, Trinkaus D et al. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med. 2004; 164(18):2038-43.
38. Schelenz S, Tucker D, Georgeu C et al. Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. J Hosp Infect. 2005; 60(2):104-10.
39. Lucet JC, Paoletti X, Lolom I et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med. 2005; 31(8):1051-7.
40. Calfee DP, Farr BM. Infection control and cost control in the era of managed care. Infect Control Hosp Epidemiol. 2002; 23(7):407-10.
41. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol. 1999; 20(6):408-11.
42. Papia G, Louie M, Tralla A et al. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol. 1999; 20(7):473-7.
43. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2002; 51(2):126-32.
44. Huang SS, Rifas-Shiman SL, Warren DK et al. Improving methicillin- resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis. 2007; 195(3):330-8.
45. Haley RW, Cushion NB, Tenover FC et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis. 1995; 171(3):614-24.
46. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis. 2008; 46(11):1717-25.
47. Manian FA, Senkel D, Zack J, Meyer L. Routine screening for methicillin-resistant Staphylococcus aureus among patients newly admitted to an acute rehabilitation unit. Infect Control Hosp Epidemiol. 2002; 23(9):516-9.
48. Brenwald NP, Baker N, Oppenheim B. Feasibility study of a real-time PCR test for meticillin-resistant Staphylococcus aureus in a point of care setting. J Hosp Infect. 2009; 74(3):245-9.
49. Vonberg RP, Stamm-Balderjahn S, Hansen S et al. How often do asymptomatic healthcare workers cause methicillin-resistant Staphylococcus aureus outbreaks? A systematic evaluation. Infect Control Hosp Epidemiol. 2006; 27(10):1123-7.
50. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis. 2008; 8(5):289-301.
51. Bradley SF. Eradication or decolonization of methicillin-resistant Staphylococcus aureus carriage: what are we doing and why are we doing it? Clin Infect Dis. 2007; 44(2):186-9.
52. Humphreys H. Can we do better in controlling and preventing methicillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit (ICU)? Eur J Clin Microbiol Infect Dis. 2008; 27(6):409-13.
53. Bleasdale SC, Trick WE, Gonzalez IM et al. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med. 2007; 167(19):2073-9.
54. Simor AE, Daneman N. Staphylococcus aureus decolonization as a prevention strategy. Infect Dis Clin North Am. 2009; 23(1):133-51.
55. Mahamat A, MacKenzie FM, Brooker K et al. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents. 2007; 30(2):169-76.
56. Rampling A, Wiseman S, Davis L et al. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2001; 49(2):109-16.
57. Schmitz FJ, Verhoef J, Idel H et al. Impact of hygienic measures on the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital. J Hosp Infect. 1998; 38(3):237-40.
58. French GL, Otter JA, Shannon KP et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect. 2004; 57(1):31-7.
59. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006; 166(18):1945-51.
60. Goodman ER, Platt R, Bass R et al. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol. 2008; 29(7):593-9.
61. Clements A, Halton K, Graves N et al. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis. 2008; 8(7):427-34.
62. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R. Methicillin- resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol. 1999; 20(1):31-6.
63. Washio M, Mizoue T, Kajioka T et al. Risk factors for methicillin- resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital. Public Health. 1997; 111(3):187-90.
64. Khan OA, Weston VC, Scammell BE. Methicillin-resistant Staphylococcus aureus incidence and outcome in patients with neck of femur fractures. J Hosp Infect. 2002; 51(3):185-8.
65. Muller AA, Mauny F, Bertin M et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis. 2003; 36(8):971-8.
66. Harbath S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in Gram-negative bacilli. Clin Infect Dis. 2001; 33(9):1462-8.
67. Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital- acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect. 2001; 127(3):443-50.
68. Hoiby N, Jarlov JO, Kemp M et al. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet. 1997; 349(9046):167-9.
69. Fukatsu K, Saito H, Matsuda T et al. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin- resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg. 1997; 132(12):1320-5.
70. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis. 1999; 28(5):1062-6.
71. Gruson D, Hilbert G, Vargas F et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):837-43.
72. Vivoni AM, Santos KR, de-Oliveira MP et al. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect Control Hosp Epidemiol. 2005; 26(7):662-7.
73. Perez-Roth E, Lopez-Aguilar C, Alcoba-Florez J, Mendez-Alvarez S. High-level mupirocin resistance within methicillinresistant Staphylococcus aureus pandemic lineages. Antimicrob Agents Chemother. 2006; 50(9):3207-11.
74. Alvarez CA, Barrientes OJ, Leal AL et al. Community-associated methicillin-resistant Staphylococcus aureus, Colombia. Emerg Infect Dis. 2006; 12(12):2000-1.
75. Palombarani S, Gardella N, Tuduri A et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in a hospital for acute diseases. Rev Argent Microbiol. 2007; 39(3):151-5.
76. Ribeiro A, Dias C, Silva-Carvalho MC et al. First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America. J Clin Microbiol. 2005; 43(4):1985-8.
77. Benoit SR, Estivariz C, Mogdasy C et al. Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcare-associated infections, Uruguay, 2002-2004. Emerg Infect Dis. 2008; 14(8):1216-23.
78. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA. 2007; 298(15):1763-71.
79. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008; 46(6):787-94.
80. DL. Community-acquired Staphylococcus aureus infections: Increasing virulence and emerging methicillin resistance in the new millennium. Curr Opin Infect Dis. 2003; 16(3):189-91.
81. Herold BC, Immergluck LC, Maranan MC et al. Community- acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998; 279(8):593-8.
82. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin- resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003; 36(2):131-9.
83. Farley JE. Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community- acquired methicillin-resistant Staphylococcus aureus. J Am Acad Nurse Pract. 2008; 20(2):85-92.
84. Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep. 2007; 33(4):45-8.
85. Centers for Disease Control and Prevention. Community-associated MRSA information for clinicians. 2005.
86. Los Angeles County Department of Public Health. Guidelines for Reducing the Spread of Staph/CAMRSA in Non-Healthcare Settings v. 2. 2007.
87. California Department of Public Health Division of Communicable Disease Control. Community-associated (CAMRSA)/ Staph Infections: A Guideline for Athletic Departments. 2007.
88. European Antimicrobial Resistance Surveillance System. Annual Report. The National Institute for Public Health and Environment (RIVM), 2003.
89. Wertheim HF, Vos MC, Boelens HA et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004; 56(4):321-5.
90. Guerra CM, Ramos MP, Penna VZ et al. Perceptions and attitudes of the professional staff concerning infection surveillance and control programs in Brazilian hospitals. Am J Infect Control. 2009; 38(1):59-62.